Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20139Active, not recruiting
Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by N/A. Primary endpoint: Percentage of patients reaching DAS28 < 2.6. Started Jan 2006; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20139.